Trend Screener

Sun Pharmaceutical Industries Share Price SUNPHARMA

Sun Pharmaceutical Industries Limited
Open Chart
₹1,861.00
-0.21%
Today High / Low ₹1,875.30 / ₹1,840.50
52W High / Low ₹2,046.90 / ₹1,548.00
Trend Screener Score 20%  |  Very Strong Bearish

SUNPHARMA Trend Matrix

Monthly Trend Bearish / Res.. - ₹1,983.20
Weekly Trend Bearish / Res.. - ₹1,917.00
Daily Trend Bearish / Res.. - ₹1,892.60
Hourly Trend Bearish / Res.. - ₹1,852.50
15M Trend Bullish / Sup.. - ₹1,850.00
CMP vs S/R YES

RSI Momentum Values

Monthly RSI 57.18
Weekly RSI 51.03
Daily RSI 37.52

Moving Average Confluence (SMA)

SMA 200 ₹1,805.66
SMA 100 ₹1,878.23
SMA 50 ₹1,930.05
SMA 20 ₹1,906.28
SMA 10 ₹1,908.73
Overall Trend: Trend is weak and sellers are still in control. Until the price starts showing strength again, any upside move may struggle to continue.

Momentum: RSI is close to the middle range (around 48.58), so there is no strong momentum on either side right now. Lower timeframes are sending mixed signals, pointing to some short-term choppiness.

Moving Averages: Price is trading below most major moving averages. Recovery signs are visible, but the trend needs more confirmation. However, the price is still above the 200-day SMA, which keeps the long-term trend positive.

Key Levels: The next major resistance is near ₹1,983.20. The nearest resistance is around ₹1,917.00. Today's range has been between ₹1,840.50 and ₹1,875.30. The stock is positioned right in the middle of its 52-week range.

Trend Summary: Very Strong Bearish. The trend is still weak. It is better to wait for a clear sign of strength before considering fresh buying.
Market Capitalisation See Ratios Below ↓
Key Statements See Ratios Below ↓

About Sun Pharmaceutical Industries

Sun Pharmaceutical Industries Limited is a pharmaceutical company that develops, manufactures and markets branded medicines, generic formulations and active pharmaceutical ingredients. Its products cover therapeutic areas including cardiology, diabetes, gastroenterology, dermatology, ophthalmology, oncology, neurology, respiratory care and pain management. The company also offers specialty medicines, over-the-counter products and a range of pharmaceutical ingredients. Sun Pharma serves India, the United States and other international markets. Founded in 1983, the company is headquartered in Mumbai, India.

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic Website: Official Website

Similar Stocks (NIFTY 50 Peers)

Sun Pharmaceutical Industries Limited (Sun Pharmaceutical Industries) Share Price & Technical Analysis

Track the latest Sun Pharmaceutical Industries Limited share price along with important technical indicators in one place. This page provides a quick overview of the stock's current trend, momentum, and key price levels without switching between multiple charts.

You can check the live market price, Monthly, Weekly, Daily and Intraday trends, RSI values, Moving Averages (SMA), support & resistance levels, and the stock's 52-week high and low to better understand its overall market position.

Trend Screener automatically updates market data throughout trading hours, helping traders and investors stay informed with the latest technical analysis and trend information for 250+ NSE stocks.

Sun Pharmaceutical Industries Limited (Sun Pharmaceutical Industries) Technical Analysis Overview

This page brings together the most important technical indicators for Sun Pharmaceutical Industries Limited in one place. Instead of checking multiple charts, you can quickly review the stock's price action, trend, momentum, and key support and resistance levels from a single dashboard.

Whether you are an intraday trader, swing trader, or long-term investor, this page helps you quickly understand the current technical picture of Sun Pharmaceutical Industries before making your own investment decisions.

Disclaimer: TrendScreener.in is an educational stock analysis platform and is not a SEBI-registered Research Analyst or Investment Advisor. The information on this page is generated using technical indicators and market data and should not be considered as investment advice or buy/sell recommendations. Please do your own research before investing.